3P Biopharmaceuticals has expanded its analytical capacities and capabilities. The 3P Analytical Development Area is one of the company’s core competences and has been significantly upgraded with an investment of around $500,000.
 
In addition to the area expansion, 3P has also invested in state-of-the-art equipment and technology that increases its capabilities to support clients various needs for analytical methods development, process development and manufacturing of biopharmaceuticals.
 
3P also offers analytical solutions in the later stages of the biopharmaceuticals ́ development, including process characterization, which ensures successful entrance to the market.